{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:36:05Z","timestamp":1788777365059,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11926-024-01175-4","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T02:50:44Z","timestamp":1735354244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Role of Podocytes in Lupus Pathology"],"prefix":"10.1007","volume":"27","author":[{"given":"Kayaho","family":"Maeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George C.","family":"Tsokos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,28]]},"reference":[{"key":"1175_CR1","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC. Mechanisms of Disease systemic lupus erythematosus. N Engl J Med. 2011;365:2110\u201331.","journal-title":"N Engl J Med."},{"key":"1175_CR2","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/art.39594","volume":"68","author":"MG Tektonidou","year":"2016","unstructured":"Tektonidou MG, Dasgupta A, Ward MM. Risk of end-stage renal disease in patients with Lupus Nephritis, 1971\u20132015: a systematic review and bayesian Meta-analysis. Arthritis Rheumatol. 2016;68:1432\u201341.","journal-title":"Arthritis Rheumatol"},{"key":"1175_CR3","doi-asserted-by":"crossref","unstructured":"Yu F, Haas M, Glassock R, Zhao MH. Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol Nat. 2017;13:483\u201395 (Publishing Group).","DOI":"10.1038\/nrneph.2017.85"},{"key":"1175_CR4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2215\/CJN.06720615","volume":"11","author":"W Hu","year":"2016","unstructured":"Hu W, Chen Y, Wang S, Chen H, Liu Z, Zeng C, et al. Clinical\u2013morphological features and outcomes of lupus podocytopathy. Clin J Am Soc Nephrol. 2016;11:585\u201392.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1175_CR5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","volume":"21","author":"GC Tsokos","year":"2020","unstructured":"Tsokos GC. Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol Nat Res. 2020;21:605\u201314.","journal-title":"Nat Immunol Nat Res"},{"key":"1175_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41581-023-00786-x","volume":"20","author":"GC Tsokos","year":"2024","unstructured":"Tsokos GC, Boulougoura A, Kasinath V, Endo Y, Abdi R, Li H. The immunoregulatory roles of non-haematopoietic cells in the kidney. Nat Rev Nephrol Nat Res; 2024;20:206\u201317.","journal-title":"Nat Rev Nephrol Nat Res"},{"key":"1175_CR7","doi-asserted-by":"crossref","unstructured":"Perico L, Conti S, Benigni A, Remuzzi G. Podocyte-actin dynamics in health and disease. Nat Rev Nephrol. 2016;12:692\u2013710 (Nature Publishing Group).","DOI":"10.1038\/nrneph.2016.127"},{"key":"1175_CR8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1681\/ASN.2021060794","volume":"33","author":"AJB Watts","year":"2022","unstructured":"Watts AJB, Keller KH, Lerner G, Rosales I, Collins AB, Sekulic M, et al. Discovery of autoantibodies Targeting Nephrin in Minimal Change Disease supports a novel autoimmune etiology. J Am Soc Nephrol. 2022;33:238\u201352.","journal-title":"J Am Soc Nephrol"},{"key":"1175_CR9","doi-asserted-by":"crossref","unstructured":"Hengel FE, Dehde S, Lass\u00e9 M, Zahner G, Seifert L, Schnarre A et al. Autoantibodies targeting nephrin in Podocytopathies. N Engl J Med. 2024;391(5):422-433.","DOI":"10.1056\/NEJMoa2314471"},{"key":"1175_CR10","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1172\/JCI200523371","volume":"115","author":"K Asanuma","year":"2005","unstructured":"Asanuma K, Kim K, Oh J, Giardino L, Chabanis S, Faul C, et al. Synaptopodin regulates the actin-bundling activity of \u03b1-actinin in an isoform-specific manner. J Clin Invest. 2005;115:1188\u201398.","journal-title":"J Clin Invest"},{"issue":"9","key":"1175_CR11","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3390\/jcm8091340","volume":"8","author":"H Sakhi","year":"2019","unstructured":"Sakhi H, Moktefi A, Bouachi K, Audard V, H\u00e9nique C, Remy P, et al. Podocyte injury in lupus nephritis. J Clin Med MDPI. 2019;8(9):1340.","journal-title":"J Clin Med MDPI."},{"key":"1175_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/0961203313517152","volume":"23","author":"GM Rezende","year":"2014","unstructured":"Rezende GM, Viana VS, Malheiros DMAC, Borba EF, Silva NAS, Silva C, et al. Podocyte injury in pure membranous and proliferative lupus nephritis: distinct underlying mechanisms of proteinuria? Lupus. 2014;23:255\u201362.","journal-title":"Lupus"},{"key":"1175_CR13","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/art.39026","volume":"67","author":"M Dall\u2019Era","year":"2015","unstructured":"Dall\u2019Era M, Cisternas MG, Smilek DE, Straub L, Houssiau FA, Cervera R, et al. Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the euro-lupus nephritis cohort. Arthritis Rheumatol. 2015;67:1305\u201313.","journal-title":"Arthritis Rheumatol"},{"key":"1175_CR14","doi-asserted-by":"crossref","unstructured":"Nagata M. Podocyte injury and its consequences. Kidney Int. 2016;89:1221\u201330 (Elsevier B.V.).","DOI":"10.1016\/j.kint.2016.01.012"},{"key":"1175_CR15","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/ndt\/gfw002","volume":"31","author":"J Perez-Hernandez","year":"2016","unstructured":"Perez-Hernandez J, Olivares MD, Forner MJ, Chaves FJ, Cortes R, Redon J. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis. Nephrol Dial Transpl. 2016;31:780\u20139.","journal-title":"Nephrol Dial Transpl"},{"key":"1175_CR16","doi-asserted-by":"publisher","unstructured":"Lasagni L, Lazzeri E, Shankland SJ, Anders HJ, Romagnani P. Podocyte mitosis - a catastrophe.\u00a0Curr Mol Med.\u00a013(1):13-23. https:\/\/doi.org\/10.2174\/1566524011307010013.","DOI":"10.2174\/1566524011307010013"},{"issue":"24","key":"1175_CR17","doi-asserted-by":"publisher","first-page":"e171237","DOI":"10.1172\/JCI171237","volume":"133","author":"X Tian","year":"2023","unstructured":"Tian X, Pedigo CE, Li K, Ma X, Bunda P, Pell J, et al. Profilin1 is required for prevention of mitotic catastrophe in murine and human glomerular diseases. J Clin Invest. 2023;133(24):e171237.","journal-title":"J Clin Invest."},{"key":"1175_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/ncb1400","volume":"8","author":"K Asanuma","year":"2006","unstructured":"Asanuma K, Yanagida-Asanuma E, Faul C, Tomino Y, Kim K, Mundel P. Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling. Nat Cell Biol. 2006;8:485\u201391.","journal-title":"Nat Cell Biol"},{"key":"1175_CR19","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nm.1857","volume":"14","author":"C Faul","year":"2008","unstructured":"Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med. 2008;14:931\u20138.","journal-title":"Nat Med"},{"key":"1175_CR20","doi-asserted-by":"publisher","first-page":"e0132724","DOI":"10.1371\/journal.pone.0132724","volume":"10","author":"R Liao","year":"2015","unstructured":"Liao R, Liu Q, Zheng Z, Fan J, Peng W, Kong Q et al. Tacrolimus protects podocytes from injury in lupus nephritis partly by stabilizing the cytoskeleton and inhibiting podocyte apoptosis. PLoS ONE. 2015;10:e0132724.","journal-title":"PLoS ONE"},{"key":"1175_CR21","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1172\/JCI99507","volume":"128","author":"K Maeda","year":"2018","unstructured":"Maeda K, Otomo K, Yoshida N, Abu-Asab MS, Ichinose K, Nishino T, et al. CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease. J Clin Invest. 2018;128:3445\u201359.","journal-title":"J Clin Invest"},{"issue":"9","key":"1175_CR22","doi-asserted-by":"publisher","first-page":"e147789","DOI":"10.1172\/jci.insight.147789","volume":"6","author":"R Bhargava","year":"2021","unstructured":"Bhargava R, Lehoux S, Maeda K, Tsokos MG, Krishfield S, Ellezian L, et al. Aberrantly glycosylated IgG elicits pathogenic signaling in podocytes and signifies lupus nephritis. JCI Insight. 2021;6(9):e147789. https:\/\/doi.org\/10.1172\/jci.insight.147789.","journal-title":"JCI Insight."},{"key":"1175_CR23","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.kint.2017.08.031","volume":"93","author":"J Fu","year":"2018","unstructured":"Fu J, Wang Z, Lee K, Wei C, Liu Z, Zhang M, et al. Transcriptomic analysis uncovers novel synergistic mechanisms in combination therapy for lupus nephritis. Kidney Int. 2018;93:416\u201329.","journal-title":"Kidney Int"},{"key":"1175_CR24","doi-asserted-by":"crossref","unstructured":"Fu R, Wang W, Huo Y, Li L, Chen R, Lin Z et al. The mechanosensitive ion channel Piezo1 contributes to podocyte cytoskeleton remodeling and development of proteinuria in lupus nephritis. Kidney Int [Internet]. 2024;134(15):e176402.\u00a0https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253824005295","DOI":"10.1016\/j.kint.2024.06.025"},{"key":"1175_CR25","doi-asserted-by":"crossref","unstructured":"Tsokos GC. The immunology of systemic lupus erythematosus. Nat. Immunol. 2024;25(8):1332-1343 (del Nature Research).","DOI":"10.1038\/s41590-024-01898-7"},{"key":"1175_CR26","doi-asserted-by":"crossref","unstructured":"Devarapu SK, Anders HJ. Toll-like receptors in lupus nephritis. J Biomed Sci. 2018;25:1-11 (del BioMed Central Ltd.).","DOI":"10.1186\/s12929-018-0436-2"},{"key":"1175_CR27","doi-asserted-by":"publisher","first-page":"7290","DOI":"10.1038\/srep07290","volume":"4","author":"J Kimura","year":"2014","unstructured":"Kimura J, Ichii O, Miyazono K, Nakamura T, Horino T, Otsuka-Kanazawa S et al. Overexpression of toll-like receptor 8 correlates with the progression of podocyte injury in murine autoimmune glomerulonephritis. Sci Rep. 2014;4:7290.","journal-title":"Sci Rep"},{"issue":"6881","key":"1175_CR28","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/416603a","volume":"416","author":"EA Leadbetter","year":"2002","unstructured":"Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and toll-like receptors. 2002;416(6881):603\u20137. https:\/\/doi.org\/10.1038\/416603a.","journal-title":"Chromatin-IgG complexes activate B cells by dual engagement of IgM and toll-like receptors."},{"key":"1175_CR29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1172\/JCI23025","volume":"115","author":"TK Means","year":"2005","unstructured":"Means TK, Latz E, Hayashi F, Murali MR, Golenbock DT, Luster AD. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest. 2005;115:407\u201317.","journal-title":"J Clin Invest"},{"key":"1175_CR30","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1093\/ndt\/gfq058","volume":"25","author":"H MacHida","year":"2010","unstructured":"MacHida H, Ito S, Hirose T, Takeshita F, Oshiro H, Nakamura T, et al. Expression of toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis. Nephrol Dial Transpl. 2010;25:2530\u20137.","journal-title":"Nephrol Dial Transpl"},{"key":"1175_CR31","doi-asserted-by":"crossref","unstructured":"Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell. 2014;157:1013\u201322 (Elsevier B.V.).","DOI":"10.1016\/j.cell.2014.04.007"},{"key":"1175_CR32","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/art.40155","volume":"69","author":"R Fu","year":"2017","unstructured":"Fu R, Guo C, Wang S, Huang Y, Jin O, Hu H, et al. Podocyte activation of NLRP3 inflammasomes contributes to the development of Proteinuria in Lupus Nephritis. Arthritis Rheumatol. 2017;69:1636\u201346.","journal-title":"Arthritis Rheumatol"},{"key":"1175_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/cei.12723","volume":"183","author":"M Cai","year":"2016","unstructured":"Cai M, Zhou T, Wang X, Shang M, Zhang Y, Luo M, et al. DC-SIGN expression on podocytes and its role in inflammatory immune response of lupus nephritis. Clin Exp Immunol. 2016;183:317\u201325.","journal-title":"Clin Exp Immunol"},{"issue":"15","key":"1175_CR34","doi-asserted-by":"publisher","first-page":"e176402","DOI":"10.1172\/JCI176402","volume":"134","author":"J Yamaguchi","year":"2024","unstructured":"Yamaguchi J, Isnard P, Robil N, de la Grange P, Hoguin C, Schmitt A, et al. PIK3CA inhibition in models of proliferative glomerulonephritis and lupus nephritis. J Clin Invest. 2024;134(15):e176402.","journal-title":"J Clin Invest."},{"key":"1175_CR35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/path.5508","volume":"252","author":"S Li","year":"2020","unstructured":"Li S, Liu Y, He Y, Rong W, Zhang M, Li L, et al. Podocytes present antigen to activate specific T cell immune responses in inflammatory renal disease. J Pathol. 2020;252:165\u201377.","journal-title":"J Pathol"},{"key":"1175_CR36","volume-title":"Interleukin-1 3 and Tumor Necrosis Factor-ot Induce Gene Expression and Production of Leukocyte Chemotactic Factors, Colony-stimulating Factors, and Interleukin-6 in Human Mesangial Cells From the Mario Negri Institute for Pharnacological","author":"C Zoja","year":"1991","unstructured":"Zoja C, Wang JM, Bettoni S, Sironi M, Renzi D, Chiaffarino F, et al. Interleukin-1 3 and Tumor Necrosis factor-ot induce Gene expression and production of Leukocyte Chemotactic Factors, colony-stimulating factors, and Interleukin-6 in human mesangial cells from the Mario Negri Institute for Pharnacological. Am. J. OfPathology; 1991."},{"key":"1175_CR37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/ndt\/gfy195","volume":"34","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Niu L, Tang X, Feng R, Yao G, Chen W, et al. Mesenchymal stem cells prevent podocyte injury in lupus-prone B6.MRL-Faslpr mice via polarizing macrophage into an anti-inflammatory phenotype. Nephrol Dial Transpl. 2019;34:597\u2013605.","journal-title":"Nephrol Dial Transpl"},{"key":"1175_CR38","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1093\/rheumatology\/keaa793","volume":"60","author":"M Bruschi","year":"2021","unstructured":"Bruschi M, Moroni G, Sinico RA, Franceschini F, Fredi M, Vaglio A, et al. Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (part 2): prospective study. Rheumatol U K. 2021;60:3388\u201397.","journal-title":"Rheumatol U K"},{"key":"1175_CR39","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/art.39499","volume":"68","author":"K Ichinose","year":"2016","unstructured":"Ichinose K, Ushigusa T, Nishino A, Nakashima Y, Suzuki T, Horai Y, et al. Lupus Nephritis IgG induction of Calcium\/Calmodulin-Dependent protein kinase IV expression in Podocytes and Alteration of their function. Arthritis Rheumatol. 2016;68:944\u201352.","journal-title":"Arthritis Rheumatol"},{"key":"1175_CR40","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s10157-017-1489-3","volume":"22","author":"B Khullar","year":"2018","unstructured":"Khullar B, Balyan R, Oswal N, Jain N, Sharma A, Abdin MZ, et al. Interaction of CD80 with Neph1: a potential mechanism of podocyte injury. Clin Exp Nephrol. 2018;22:508\u201316.","journal-title":"Clin Exp Nephrol"},{"key":"1175_CR41","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","volume":"369","author":"C-C Yu","year":"2013","unstructured":"Yu C-C, Fornoni A, Weins A, Hakroush S, Maiguel D, Sageshima J, et al. Abatacept in B7-1\u2013Positive proteinuric kidney disease. N Engl J Med. 2013;369:2416\u201323.","journal-title":"N Engl J Med"},{"key":"1175_CR42","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1681\/ASN.2012020133","volume":"24","author":"A Goldwich","year":"2013","unstructured":"Goldwich A, Burkard M, \u00d6lke M, Daniel C, Amann K, Hugo C, et al. Podocytes are nonhematopoietic professional antigen-presenting cells. J Am Soc Nephrol. 2013;24:906\u201316.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1175_CR43","doi-asserted-by":"publisher","first-page":"114249","DOI":"10.1016\/j.celrep.2024.114249","volume":"43","author":"B Qian","year":"2024","unstructured":"Qian B, Lu R, Mao S, Chen Y, Yang M, Zhang W, et al. Podocyte SIRP\u03b1 reduction aggravates lupus nephritis via promoting T cell inflammatory responses. Cell Rep. 2024;43(5):114249.","journal-title":"Cell Rep."},{"key":"1175_CR44","doi-asserted-by":"crossref","unstructured":"Yuan DH, Jia Y, Hassan OM, Xu LY, Wu XC. LPS-Treated Podocytes Polarize Naive CD4\u2009+\u2009T Cells into Th17 and Treg Cells. BioMed Res Int. 2020;2020:8587923.","DOI":"10.1155\/2020\/8587923"},{"key":"1175_CR45","doi-asserted-by":"crossref","unstructured":"May CJ, Welsh GI, Chesor M, Lait PJ, Lee RW, FRCP MAS et al. Human Th17 cells produce a soluble mediator that increases podocyte motility via signalling pathways that mimic PAR-1 activation.\u00a0Am J Physiol Renal Physiol. 2019;317(4):F913\u201321.\u00a0www.physiology.org\/journal\/ajprenal","DOI":"10.1152\/ajprenal.00093.2019"},{"key":"1175_CR46","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1681\/ASN.2004050350","volume":"16","author":"SW Kraft","year":"2005","unstructured":"Kraft SW, Schwartz MM, Korbet SM, Lewis EJ. Glomerular podocytopathy in patients with systemic lupus erythematosus. J Am Soc Nephrol. 2005;16:175\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"1175_CR47","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/0961203317720526","volume":"27","author":"SF Wang","year":"2018","unstructured":"Wang SF, Chen YH, Chen DQ, Liu ZZ, Xu F, Zeng CH, et al. Mesangial proliferative lupus nephritis with podocytopathy: a special entity of lupus nephritis. Lupus. 2018;27:303\u201311.","journal-title":"Lupus"},{"key":"1175_CR48","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1053\/ajkd.2002.36875","volume":"40","author":"A Hertig","year":"2002","unstructured":"Hertig A, Droz D, Lesavre P, Gr\u00fcnfeld JP, Rieu P. SLE and idiopathic nephrotic syndrome: coincidence or not? Am J Kidney Dis. 2002;40:1179\u201384.","journal-title":"Am J Kidney Dis"},{"key":"1175_CR49","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/17512433.2022.2092470","volume":"15","author":"T van Gelder","year":"2022","unstructured":"van Gelder T, Lerma E, Engelke K, Huizinga RB. Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis. Expert Rev Clin Pharmacol. 2022;15:515\u201329.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1175_CR50","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1056\/NEJMc1401128","volume":"370","author":"Arthroscopic Partial Meniscectomy for Degenerative Meniscal Tear","year":"2014","unstructured":"Arthroscopic Partial Meniscectomy for Degenerative Meniscal Tear. N Engl J Med. 2014;370:1259\u201361.","journal-title":"N Engl J Med"},{"key":"1175_CR51","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000446324","volume":"133","author":"R Novelli","year":"2016","unstructured":"Novelli R, Gagliardini E, Ruggiero B, Benigni A, Remuzzi G. Another piece of the puzzle of Podocyte B7-1 expression: Lupus Nephritis. Nephron. 2016;133:129\u201338.","journal-title":"Nephron"},{"key":"1175_CR52","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1002\/art.34624","volume":"64","author":"D Wofsy","year":"2012","unstructured":"Wofsy D, Hillson JL, Diamond B. Abatacept for lupus nephritis: alternative definitions of complete response support conflicting conclusions. Arthritis Rheum. 2012;64:3660\u20135.","journal-title":"Arthritis Rheum"},{"key":"1175_CR53","doi-asserted-by":"publisher","first-page":"704526","DOI":"10.3389\/fimmu.2021.704526","volume":"12","author":"J Lee","year":"2021","unstructured":"Lee J, Park Y, Jang SG, Hong SM, Song YS, Kim MJ et al. Baricitinib attenuates autoimmune phenotype and Podocyte Injury in a murine model of systemic Lupus Erythematosus. Front Immunol. 2021;12:704526.","journal-title":"Front Immunol"},{"key":"1175_CR54","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1136\/ard-2023-224242","volume":"82","author":"XY Zhao","year":"2023","unstructured":"Zhao XY, Li SS, He YX, Yan LJ, Lv F, Liang QM, et al. SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy. Ann Rheum Dis. 2023;82:1328\u201340.","journal-title":"Ann Rheum Dis"},{"key":"1175_CR55","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.febslet.2006.12.051","volume":"581","author":"Y Takano","year":"2007","unstructured":"Takano Y, Yamauchi K, Hayakawa K, Hiramatsu N, Kasai A, Okamura M, et al. Transcriptional suppression of nephrin in podocytes by macrophages: roles of inflammatory cytokines and involvement of the PI3K\/Akt pathway. FEBS Lett. 2007;581:421\u20136.","journal-title":"FEBS Lett"},{"key":"1175_CR56","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10753-023-01935-x","volume":"47","author":"D Wu","year":"2024","unstructured":"Wu D, Jiang T, Zhang S, Huang M, Zhu Y, Chen L, et al. Blockade of Notch1 signaling alleviated Podocyte Injury in Lupus Nephritis Via Inhibition of NLRP3 inflammasome activation. Inflammation. 2024;47:649\u201363.","journal-title":"Inflammation"},{"key":"1175_CR57","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1172\/JCI73411","volume":"124","author":"T Koga","year":"2014","unstructured":"Koga T, Hedrich CM, Mizui M, Yoshida N, Otomo K, Lieberman LA, et al. CaMK4-dependent activation of AKT\/mTOR and CREM-\u03b1 underlies autoimmunity-associated Th17 imbalance. J Clin Invest. 2014;124:2234\u201345.","journal-title":"J Clin Invest"},{"key":"1175_CR58","doi-asserted-by":"publisher","first-page":"5533","DOI":"10.4049\/jimmunol.1501603","volume":"195","author":"K Otomo","year":"2015","unstructured":"Otomo K, Koga T, Mizui M, Yoshida N, Kriegel C, Bickerton S, et al. Cutting Edge: Nanogel-based delivery of an inhibitor of CaMK4 to CD4\u2009+\u2009T cells suppresses experimental autoimmune encephalomyelitis and lupus-like Disease in mice. J Immunol. 2015;195:5533\u20137.","journal-title":"J Immunol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-024-01175-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-024-01175-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-024-01175-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:04:49Z","timestamp":1770750289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-024-01175-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,28]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1175"],"URL":"https:\/\/doi.org\/10.1007\/s11926-024-01175-4","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,28]]},"assertion":[{"value":"17 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10"}}